{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:51:56Z","timestamp":1781743916390,"version":"3.54.5"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["ZIA ZICTR000410"],"award-info":[{"award-number":["ZIA ZICTR000410"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Identifying rare disease (RD) patients in electronic health records (EHRs) is difficult, as most of the over 10,000 RDs are not adequately captured by standard coding systems. To address this, we developed a semi-automated workflow to map RDs to SNOMED-CT and ICD-10 codes, enabling improved RD identification across EHR systems. The optimized workflow yielded 88.4% true RD codes in a subset of 1,715 manually curated diseases.\u00a0Using this workflow and starting with 12,003 GARD IDs mapped to ORPHANET, we obtained 12,081 SNOMED-CT and 357 ICD-10 codes representing 6,342 RDs, organized into 30 ORPHANET linearization classes. We applied these codes to the National COVID Cohort Collaborative (N3C) dataset of over 21 million patients. Among these patients, 8.46 million were identified as COVID-19 positive, of which 4.8 million were used in analyses. Among these, 316,836 (6.55%) had a preexisting RD. Logistic regression, adjusted for age and BMI, revealed that most RD classes were significantly associated with increased odds of severe COVID-19 outcomes. Notably high odds of mortality were observed for rare cardiac (OR\u2009=\u20094.07) and otorhinolaryngologic diseases (OR\u2009=\u20094.00). Hospitalization risk was also elevated across all RD classes, with the highest odds seen in otorhinolaryngologic (OR\u2009=\u20094.31) and endocrine diseases (OR\u2009=\u20093.38). This approach enables scalable RD patient identification in EHRs and highlights the need for tailored healthcare strategies to improve outcomes in RD populations.<\/jats:p>","DOI":"10.1038\/s41598-026-43020-x","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T03:46:39Z","timestamp":1776483999000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Systematic identification of rare disease patients in electronic health records enables evaluation of clinical outcomes"],"prefix":"10.1038","volume":"16","author":[{"given":"Arjun S.","family":"Yadaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Sid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hythem","family":"Sidky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenjie","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewy A.","family":"Math\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the N3C Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher G.","family":"Chute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,18]]},"reference":[{"key":"43020_CR1","unstructured":"Genetic and Rare Diseases (GARD) Information Center. Accesses June 24th. https:\/\/rarediseases.info.nih.gov\/about (2025)."},{"key":"43020_CR2","unstructured":"US Food and Drug Administration. Developing products for rare diseases and conditions. Accessed May 12, 2022. https:\/\/www.fda.gov\/industry\/developing-products-rare-diseases-conditions"},{"issue":"2","key":"43020_CR3","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41431-019-0508-0","volume":"28","author":"S Nguengang Wakap","year":"2020","unstructured":"Nguengang Wakap, S. et al. Estimating cumulative point prevalence of rare diseases: Analysis of the Orphanet database. Eur J Hum Genet. 28(2), 165\u2013173. https:\/\/doi.org\/10.1038\/s41431-019-0508-0 (2020).","journal-title":"Eur J Hum Genet."},{"issue":"4","key":"43020_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11040558","volume":"11","author":"H Althobaiti","year":"2023","unstructured":"Althobaiti, H., Seoane-Vazquez, E., Brown, L. M., Fleming, M. L. & Rodriguez-Monguio, R. Disentangling the cost of orphan drugs marketed in the United States. Healthcare 11(4), 558. https:\/\/doi.org\/10.3390\/healthcare11040558 (2023).","journal-title":"Healthcare"},{"issue":"7","key":"43020_CR5","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202217159","volume":"15","author":"G Zanello","year":"2023","unstructured":"Zanello, G. et al. Targeting shared molecular etiologies to accelerate drug development for rare diseases. EMBO Mol. Med. 15(7), e17159. https:\/\/doi.org\/10.15252\/emmm.202217159 (2023).","journal-title":"EMBO Mol. Med."},{"issue":"1","key":"43020_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-024-02177-7","volume":"24","author":"LR Kalankesh","year":"2024","unstructured":"Kalankesh, L. R. & Monaghesh, E. Utilization of EHRs for clinical trials: A systematic review. BMC Med. Res. Methodol. 24(1), 70. https:\/\/doi.org\/10.1186\/s12874-024-02177-7 (2024).","journal-title":"BMC Med. Res. Methodol."},{"issue":"3","key":"43020_CR7","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jclinepi.2005.08.008","volume":"59","author":"RL Tannen","year":"2006","unstructured":"Tannen, R. L., Weiner, M. G. & Marcus, S. M. Simulation of the Syst-Eur randomized control trial using a primary care electronic medical record was feasible. J. Clin. Epidemiol. 59(3), 254\u2013264. https:\/\/doi.org\/10.1016\/j.jclinepi.2005.08.008 (2006).","journal-title":"J. Clin. Epidemiol."},{"issue":"11","key":"43020_CR8","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.ijmedinf.2014.08.005","volume":"83","author":"B Schreiweis","year":"2014","unstructured":"Schreiweis, B. et al. Comparison of electronic health record system functionalities to support the patient recruitment process in clinical trials. Int. J. Med. Inform. 83(11), 860\u2013868. https:\/\/doi.org\/10.1016\/j.ijmedinf.2014.08.005 (2014).","journal-title":"Int. J. Med. Inform."},{"issue":"1","key":"43020_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-015-0251-8","volume":"10","author":"S Aym\u00e9","year":"2015","unstructured":"Aym\u00e9, S., Bellet, B. & Rath, A. Rare diseases in ICD11: Making rare diseases visible in health information systems through appropriate coding. Orphanet J. Rare Dis. 10(1), 35. https:\/\/doi.org\/10.1186\/s13023-015-0251-8 (2015).","journal-title":"Orphanet J. Rare Dis."},{"key":"43020_CR10","unstructured":"ICD-10-CM Official Guidelines for Coding and Reporting. October 1, 2024 - September 30 (2025)."},{"key":"43020_CR11","unstructured":"Classification of Diseases, Functioning, and Disability. June 7. https:\/\/www.cdc.gov\/nchs\/icd\/icd-10-cm\/index.html#:~:text=Introduction,established%20ICD%20structure%20and%20conventions (2024)."},{"key":"43020_CR12","unstructured":"SNOMED CT to ICD-10-CM Map. https:\/\/www.nlm.nih.gov\/research\/umls\/mapping_projects\/snomedct_to_icd10cm.html"},{"key":"43020_CR13","unstructured":"OHDSI: Chapter 4. The common data model. In: The Book of OHDSI: Observational Health Data Sciences and Informatics. (OHDSI, 2020). https:\/\/ohdsi.github.io\/TheBookOfOhdsi\/CommonDataModel.html"},{"issue":"D1","key":"43020_CR14","doi-asserted-by":"publisher","first-page":"D712","DOI":"10.1093\/nar\/gkw1128","volume":"45","author":"CJ Mungall","year":"2017","unstructured":"Mungall, C. J. et al. The Monarch Initiative: An integrative data and analytic platform connecting phenotypes to genotypes across species. Nucleic Acids Res. 45(D1), D712\u2013D722. https:\/\/doi.org\/10.1093\/nar\/gkw1128 (2017).","journal-title":"Nucleic Acids Res."},{"key":"43020_CR15","unstructured":"Mondo Disease Ontology. Accessed November 9. https:\/\/mondo.monarchinitiative.org\/. (2020)."},{"key":"43020_CR16","unstructured":"Orphanet \u2013 Know the rare for better care. https:\/\/www.orphadata.com"},{"issue":"2","key":"43020_CR17","doi-asserted-by":"publisher","first-page":"e145","DOI":"10.1016\/S2589-7500(24)00253-X","volume":"7","author":"JH Thygesen","year":"2025","unstructured":"Thygesen, J. H. et al. Prevalence and demographics of 331 rare diseases and associated COVID-19-related mortality among 58 million individuals: A nationwide retrospective observational study. Lancet Digit Health 7(2), e145\u2013e156. https:\/\/doi.org\/10.1016\/S2589-7500(24)00253-X (2025).","journal-title":"Lancet Digit Health"},{"key":"43020_CR18","first-page":"340","volume":"2018","author":"R Colbaugh","year":"2018","unstructured":"Colbaugh, R., Glass, K. & Rudolf, C. Tremblay Volv Global Lausanne Switzerland M. Learning to identify rare disease patients from electronic health records. AMIA Annu Symp Proc. 2018, 340\u2013347 (2018).","journal-title":"AMIA Annu Symp Proc."},{"issue":"7","key":"43020_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0235574","volume":"15","author":"AM Cohen","year":"2020","unstructured":"Cohen, A. M. et al. Detecting rare diseases in electronic health records using machine learning and knowledge engineering: Case study of acute hepatic porphyria. PLoS ONE 15(7), e0235574. https:\/\/doi.org\/10.1371\/journal.pone.0235574 (2020).","journal-title":"PLoS ONE"},{"issue":"1","key":"43020_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-75912-x","volume":"10","author":"A Martin","year":"2020","unstructured":"Martin, A. et al. An artificial intelligence-based first-line defence against COVID-19: Digitally screening citizens for risks via a chatbot. Sci. Rep. 10(1), 19012. https:\/\/doi.org\/10.1038\/s41598-020-75912-x (2020).","journal-title":"Sci. Rep."},{"key":"43020_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1108222","volume":"14","author":"S Lin","year":"2023","unstructured":"Lin, S. et al. An artificial intelligence-based approach for identifying rare disease patients using retrospective electronic health records applied for Pompe disease. Front. Neurol. 14, 1108222. https:\/\/doi.org\/10.3389\/fneur.2023.1108222 (2023).","journal-title":"Front. Neurol."},{"issue":"1","key":"43020_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-55424-8","volume":"14","author":"D Moynihan","year":"2024","unstructured":"Moynihan, D. et al. Analysis and visualisation of electronic health records data to identify undiagnosed patients with rare genetic diseases. Sci. Rep. 14(1), 5056. https:\/\/doi.org\/10.1038\/s41598-024-55424-8 (2024).","journal-title":"Sci. Rep."},{"issue":"1","key":"43020_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-023-02868-2","volume":"18","author":"A Wilson","year":"2023","unstructured":"Wilson, A. et al. Development of a rare disease algorithm to identify persons at risk of Gaucher disease using electronic health records in the United States. Orphanet J. Rare Dis. 18(1), 280. https:\/\/doi.org\/10.1186\/s13023-023-02868-2 (2023).","journal-title":"Orphanet J. Rare Dis."},{"key":"43020_CR24","doi-asserted-by":"publisher","unstructured":"Reese, J. T., Chimirri, L., Bridges, Y. et al. Systematic Benchmarking Demonstrates Large Language Models have not Reached the Diagnostic Accuracy of Traditional Rare-Disease Decision Support Tools. Published online July 22. https:\/\/doi.org\/10.1101\/2024.07.22.24310816 (2024).","DOI":"10.1101\/2024.07.22.24310816"},{"key":"43020_CR25","unstructured":"World Health Organization. Tracking SARS-CoV-2 variants. Accessed April 11 (2022)."},{"issue":"7","key":"43020_CR26","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.16901","volume":"4","author":"TD Bennett","year":"2021","unstructured":"Bennett, T. D. et al. Clinical characterization and prediction of clinical severity of SARS-CoV-2 infection among US adults using data from the US National COVID Cohort Collaborative. JAMA Netw. Open 4(7), e2116901. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.16901 (2021).","journal-title":"JAMA Netw. Open"},{"issue":"3","key":"43020_CR27","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/jamia\/ocaa196","volume":"28","author":"MA Haendel","year":"2021","unstructured":"Haendel, M. A. et al. The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment. J Am Med Inform Assoc. 28(3), 427\u2013443. https:\/\/doi.org\/10.1093\/jamia\/ocaa196 (2021).","journal-title":"J Am Med Inform Assoc."},{"key":"43020_CR28","unstructured":"The Observational Health Data Sciences and Informatics (OHDSI). https:\/\/atlas.ohdsi.org\/#\/home"},{"issue":"1","key":"43020_CR29","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ajhg.2015.05.020","volume":"97","author":"T Groza","year":"2015","unstructured":"Groza, T. et al. The Human Phenotype Ontology: Semantic unification of common and rare disease. Am. J. Hum. Genet. 97(1), 111\u2013124. https:\/\/doi.org\/10.1016\/j.ajhg.2015.05.020 (2015).","journal-title":"Am. J. Hum. Genet."},{"key":"43020_CR30","unstructured":"Linearization rules for ORPHANET classifications. https:\/\/www.orpha.net\/pdfs\/orphacom\/cahiers\/docs\/GB\/Orphanet_linearisation_rules.pdf"},{"key":"43020_CR31","unstructured":"The N3C Data Enclave represents one of the largest secure collections of harmonized clinical health data in the United States. October 10. https:\/\/covid.cd2h.org\/dashboard\/ (2024)."},{"issue":"1","key":"43020_CR32","doi-asserted-by":"publisher","DOI":"10.32614\/RJ-2021-053","volume":"13","author":"DD Sjoberg","year":"2021","unstructured":"Sjoberg, D. D., Whiting, K., Curry, M., Lavery, J. A. & Larmarange, J. Reproducible summary tables with the gtsummary package. R J. 13(1), 570. https:\/\/doi.org\/10.32614\/RJ-2021-053 (2021).","journal-title":"R J."},{"issue":"3","key":"43020_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(24)00056-1","volume":"12","author":"The Lancet Global Health","year":"2024","unstructured":"The Lancet Global Health. The landscape for rare diseases in 2024. Lancet Glob. Health 12(3), e341. https:\/\/doi.org\/10.1016\/S2214-109X(24)00056-1 (2024).","journal-title":"Lancet Glob. Health"},{"issue":"1","key":"43020_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-021-01994-z35","volume":"16","author":"CCY Chung","year":"2021","unstructured":"Chung, C. C. Y., Wong, W. H. S. & Chung, B. H. Y. Hospital mortality in patients with rare diseases during pandemics: Lessons learnt from the COVID-19 and SARS pandemics. Orphanet J. Rare Dis. 16(1), 361. https:\/\/doi.org\/10.1186\/s13023-021-01994-z35 (2021).","journal-title":"Orphanet J. Rare Dis."},{"issue":"7","key":"43020_CR35","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-062126.36","volume":"12","author":"GM Abozaid","year":"2022","unstructured":"Abozaid, G. M., Kerr, K., McKnight, A. & Al-Omar, H. A. Criteria to define rare diseases and orphan drugs: A systematic review protocol. BMJ Open 12(7), e062126. https:\/\/doi.org\/10.1136\/bmjopen-2022-062126.36 (2022).","journal-title":"BMJ Open"},{"key":"43020_CR36","doi-asserted-by":"crossref","unstructured":"Health NIo. Public Law 107\u2013280\u2014NOV. 6, 2002. In: 2002 RDA. (2002).","DOI":"10.1089\/10921880252853439"},{"key":"43020_CR37","unstructured":"United States Census Bureau access on August 27th. https:\/\/www.census.gov\/data.html (2025)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43020-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43020-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43020-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:05:32Z","timestamp":1781741132000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43020-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["43020"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-43020-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,18]]},"assertion":[{"value":"28 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18987"}}